More Weight Loss Solutions

Archives

Archive for the ‘Testosterone’ Category

Every day on social media we see soaring stories of people standing tall. But what about the moments we live small?

Lately I've been loitering inside my memory bank with an experience that no matter how I twist and contort to escape, it has no alternate ending.

I lived small.

I was a junior in high school when I landed a beefy role in a play. I'd been acting for a few years and was thrilled my dynamite drama teacher and director had trusted me with the part.

We had little time to prepare and I'll never forget reading the script for the first time. The dialogue fizzed and popped like an afterschool Pepsi.

And then it all went flat.

My character had one particularly profane line that I shouldn't, wouldn't, couldn't say. I'd never said those words. I still don't.

At our first rehearsal I mumble-whispered the line and hoped with so many distractions on stage the director wouldn't notice.

She didn't.

Over three wild weeks of rehearsals, I convinced myself I could keep faking it. Then, when the curtain finally rose with an audience, maybe I'd feel fine about saying it just once at full volume.

On the night of the open dress rehearsal, I was nervous to see an older couple from church - the Ehlers - seated in the auditorium. They were forever friends of our family and I had no idea they'd be there.

When the big moment arrived - with adrenaline, testosterone, and gummy bears racing through my system - I went for it.

$#*%!

I remember the moment. Where I stood. How it sounded. How I felt.

After the show, the Ehlers met me in the school lobby with cheers, a hug, and some snappy dialogue of their own.

Certainly after all these years this cannot be considered verbatim. Still, sadly, I know it's close. Regrets have a way of adding color to otherwise gray memories.

Mrs. Ehlers looked at me. "Jason, that was quite some language. You surprised us."

"I know. I didn't want to say it."

"Why didn't you tell the director you didn't want to say the line? I bet you could have changed it."

I studied my black and white checkered sneakers. "She wouldn't have let me," I said.

"Maybe," Mrs. Ehlers said with a soft smile. "Or maybe not. But we have to stand up sometimes, don't we? Either way, we're proud of you."

I said goodbye and lingered around the drama room until our director appeared and the other cast members vanished.

With my heart thumping and my palms sweating, I stood near her desk and casually asked if I might maybe, sort of, I don't know, possibly perhaps like change the profane line in the play to something more PG.

"Of course! You're right. We really should. I wish you'd said something earlier."

Ouch.

Soon I walked away juggling gratitude, humility, respect, and shame.

Later when I relayed the story to the Ehlers, they gave me more cheers, hugs and unconditional love.

So, how about that alternate ending?

Why didn't I immediately make a stand? Why hadn't I clung to my standards? Refused to bend? I could have made my case without ego, pride, or self-righteous judgement.

What a story it could've been!

"Hey kids. Have I ever told you about the time I made a tough call and refused to give in?"

Instead, my spine shrank. It was a golden moment to be brave, to speak up, to stand tall.

Instead I was weak, went silent, lived small.

Years later I can remember other times I handled those character moments much better. How thankful I am for those second chances.

Yet here I am, sharing a what-if regret in the spirit of transparency.

If we can't share the good times with the bad and the falls and failures with the big wins, what's the point of sharing at all?

Life and her hard lessons aren't meant to be lived and learned through a fancy filter.

Because heaven knows the moments we live small are just as important in our book of life as the days we stand tall.

Jason F. Wright is a New York Times bestselling author, columnist, and speaker. His newest book, "Seen, Loved, Lifted: How Seeing, Loving and Lifting Others Can Change Your Life" is available at Amazon. Join Jason on Facebook, Instagram and Twitter.

Read the original:
Jason F. Wright: The day I went silent, lived small - Northern Virginia Daily

Comments Off on Jason F. Wright: The day I went silent, lived small – Northern Virginia Daily
Jul 18th, 2020 | Filed under Testosterone

(UroToday.com)In this debate, a clinical case of a 65-year-old gentleman who was diagnosed with prostate cancer Gleason grade group 2 on biopsy was presented byGiorgio Gandaglia, MD. The patient underwent robotic-assisted radical prostatectomy, demonstrating pT3a, Gleason grade group 4 with negative margins on final pathology, with no lymph node dissection performed. The first postoperative prostate-specific antigen (PSA) was undetectable, but later, PSA started to rise from 0.25 to 0.65 with a PSA doubling time of 1.4 months. The patient received salvage radiotherapy to the prostatic fossa and pelvic lymph nodes + concomitant androgen deprivation therapy (ADT) for 36 months.

Following salvage treatment, the PSA started to rise again from a nadir of 0.1 to 0.3, 1.2, and finally, 1.5 ng/ml with castrated testosterone. The patient was defined as having castrate-resistant prostate cancer. The patient had a negative multiparametric magnetic resonance imaging (MRI) and a negative bone scan, an abdominal pelvic CT scan. Later, PET prostate-specific membrane antigen (PSMA) was performed and showed two positive spots in the common iliac and presacral lymph nodes (Figure 1). The question that was presented by Dr. Gandaglia was whether this patient should be considered for androgen receptor-targeted treatment (ARTA).

Figure 1 Positive PET PSMA in the presented patient:

First, Alicia Morgans, MD, MPH, discussed why she believes ARTA should be given to this patient.According to Dr. Morgans, regardless of molecular imaging results, patients with rising PSA on ADT with conventional negative imaging meet the trial definition of M0 CRPC.The important question is whether this patient has M0 CRPC or oligo-progressive mCRPC and whether he could have both, and if so, does it really matter?

M0 CRPC occurs in patients with:

Oligo-progressive oligo-metastatic CRPC occurs in patients with:

In the next part of the discussion, Dr. Morgans discussed the various available treatment options for these patients. She began with metastasis directed therapy (MDT) in M0 CRPC. In a retrospective analysis, targeted ablation of three or fewer sites identified by molecular or standard imaging was performed. PSA doubling time and freedom from progression were calculated. In this retrospective analysis, 73% had a PSA response with a mean of 86% reduction of PSA and a clear advantage in patients treated with ARAT (Figure 2).

Figure 2 Metastasis directed therapy in patients with oligometastatic prostate cancer1

In another retrospective analysis2, MDT was associated with an improved median time to PSA failure, time to next intervention, and distant metastases free-survival. The challenges with studies of MDT in M0 CRPC include the fact that these are mostly retrospective analysis with variability in the treatments and imaging used. Most studies are small and nonrandomized. The studies do not regularly include currently available next-generation AR antagonist treatment, and the outcomes may not be meaningful or rigorously documented.

To date, the only level one evidence of benefit has been shown by providing intensified systemic therapy, in the form of either apalutamide, darolutamide, or enzalutamide to patients with MO CRPC and a high risk of developing Metastasis (PSA doubling time of fewer than ten months). This level one evidence comes from the three recently landmark published trials, SPARTAN3, PROSPER4, and ARAMIS5 (Figure 3). All three trials demonstrated significant improvement in metastases free survival (Figure 4) and overall survival in the updated results (Figure 5). Importantly, Enzalutamide and apalutamide were associated with stable to improved quality of life.

Figure 3 ARAMIS, PROSPER, and SPARTAN trials:

Figure 4 - Metastasis free survival in ARAMIS, PROSPER, and SPARTAN:

Figure 5 - Overall survival in ARAMIS, PROSPER, and SPARTAN trials:

Therefore, regardless of molecular imaging results, level one evidence suggests improved metastasis-free survival, overall survival, and quality of life associated with ARAT in M0 CRPC patients.

Concluding her excellent talk, Dr. Morgans stated that Imaging advances blur the distinction between patient types, and applying the criteria for M0 CRPC from clinical trials still remains valid. Additionally, MDT for oligo progressive CPRC appears promising, but to date, there is insufficient evidence available to apply this outside of a clinical trial. Lastly, there is level 1 evidence, and the EAU guidelines themselves support the use of apalutamide, darolutamide, or enzalutamide for M0 CRPC with improvement in metastasis-free survival, overall survival, and quality of life.

In the last part of this debate, Jens Bedke, MD, gave a talk explaining why he thinks there is no role for ARAT in M0 CRPC.

According to Dr. Bedke, the presented patient is not a true M0 CRPC patient, as his PET PSMA was positive for two distinct lymph nodes.

The patients included in SPARTAN3 study were required to have no local or regional nodal disease (N0) or to have malignant pelvic lymph nodes that measured less than two centimeters in the short axis (N1) that were located below the aortic bifurcation. According to Dr. Bedke, the predominant effect of apalutamide was in patients with cM1a (HR 0.15), with the outcome of cM0 patients remaining to be unknown.

The time to metastases without treatment was 14-18 months in PROSPER, SPARTAN, and ARAMIS trials (Figure 6). This time to metastases in patients who did not receive any treatment is quite important as patients on these therapies had significant adverse events (Figure 7).

Figure 6 Time to metastases without treatment in PROSPER, SPARTAN, and ARAMIS:

Figure 7 Adverse events in PROSPER, SPARTAN, and ARAMIS:

The other problem in these three landmark large trials are the fact that there was a high crossover rate, with 56-65% of patients in the placebo arm receiving subsequent therapies with no clean comparison, as these trials were basically a comparison of early treatment vs. late treatment.

Additionally, phase 3 non-metastatic CRPC trials have shown a 14-18 months time to metastases without treatment. Based on this data, there is a high probability of undetected cM1 disease. In PROSPER, SPARTAN, and ARAMIS, the PSA doubling time was in the range of 3 to 8.9 months.

According to Dr. Bedke, there is a data gap in the true treatment of cM0 CRPC.

Dr. Bedke concluded his talk emphasizing that the large three trials assessing non-metastatic CRPC patients included M1a patients as well. M1 status is defined by the modality of imaging, and only PET PSMA CT can define MO CRPC and not conventional imaging. Dr. Bedke believes that not every patient with M0 CRPC needs ARTA. The PSA doubling time determines the risk of metastases and death in patients with M0 CRPC. ARTA should be given to M0 CRPC patients with PSA doubling time of fewer than three months. Lastly, it is important to remember that ARTA has significant adverse effects that need to be considered, as well.

Presented by:

Written By: Hanan Goldberg, MD, MSc., Urology Department, SUNY Upstate Medical University, Syracuse, NY, USA, Twitter: @GoldbergHananat the Virtual 2020EAUAnnual Meeting #EAU20, July 17-19, 2020.

References:

More here:
EAU 2020: M0 CRPC: Androgen Receptor Targeted Treatment (ARTA) - UroToday

Comments Off on EAU 2020: M0 CRPC: Androgen Receptor Targeted Treatment (ARTA) – UroToday
Jul 17th, 2020 | Filed under Testosterone

JACKSONVILLE, Ore. Its a name you see all over Jacksonville, but who was Beekman?

First things first, his name was Cornelius Beekman, and he opened the very first bank in the Pacific Northwest in the 1860s. Its still standing in downtown Jacksonville, but unfortunately, a lot of people seem to walk by without paying it much attention.

Local historian Ben Truwe spends a lot of time behind the counter of the Beekman Bank, full of information on why the building should pique your interest. Even if you were to enter the bank without a guide, youd find plenty relics keep you occupied.

He ran his bank here for 50 years and when he died everything was left in place, Truwe said. This is a national treasure. The board youre standing on is 150 years old.

Much of what youll find in the bank is authentic. Some of the items are so outdated, visitors play a guessing game with Truwe trying to figure out what the devices were used for. Everything from check presses and cutters, to envelope seals and vaults. Antique, dust-covered books line the floor-to-wall bookshelf, and Truwe says many of them are original to the bank. Though, he admits others are imposters.Actually, Truwe is brutally honest about any modification made to the bank to lure in tourists, including the phony back room.

Truwe said its one of Beekmans original items that draws the most attention; a giant vault that you can walk inside. Inside the safe you can see what Truwe says is 50 years of soot and cigar smoke on the walls, as well as a tin of marshmallows.

Yeah, Beekman liked marshmallows, Truwe said with a laugh.

While the vault appears quite impressive to anyone who sees it, Truwe said it would not have been hard to rob the Beekman Bank back in the 1860s.

It was a lot of smoke and mirrors, Truwe said. He went on to explain that the walls of the big safe were thick and sturdy, but a quick tap on the roof and door is proof that the safe was wellnot so safe.

Pretty much put together with a bunch of junk, Truwe said.It was to impress the miners that this was the place to do business.

So, Beekmans safe may not have been the safest place to store gold or cash, but thats not exactly how he operated.

When you sold your gold either that would give you an account on Beekmans bank that you could draw on, or he would give you a Wells Fargo check, Truwe explained. A Wells Fargo check you could cash anywhere in the world. So it was better than money.

Back to where we started, who exactly is Beekman? Like many men in the 1850s, Beekman came out west with the Gold Rush, arriving in Jacksonville in 1853.

5,000 young, single testosterone-fueled men digging in the dirt trying to make their fortune, Truwe said. He went on to explain that Beekman would travel back and forth to Yreka (about a 20 hour round trip at the time) several times a week.

Well, he was in his 20s he was superman he could tolerate that, Truwe added.

When the company Beekman rode for went bankrupt, he decided to buy it. Then, Beekmans Express became a Wells Fargo agency and, in 1862, it became a bank.

[Beekman Bank] was actually the first bank in Oregon territory. There were no banks north of California when this bank began, Truwe said.

Its a place where southern Oregons history is still intact, and yet, Truwe says too many people just walk on buy without taking so much as a glance.

People will come in and look at the brochures Stick their head in and then theyll leave, Truwe said. Who knows they could come in and I could sell them a timeshare. It could be that bad!

Its far from a timeshare, but if you visit the Beekman Bank, you will take a trip through time.

Theres a national treasure here that you really shouldnt miss.

NBC5 News anchor and reporter Kristina Zagame is from Boston, Massachusetts. She comes to us from KQTV in St. Joseph, Missouri where she was the evening anchor and executive producer.

Kristina received her degree in Broadcast Journalism from the University of South Carolina. She spent a summer interning for an international online magazine in Santiago, Chile. She also covered Hurricane Maria relief efforts in the Virgin Islands.

When shes not in the newsroom, Kristina loves exploring, dancing and live music.

See the original post here:
Unknown Stories Pt. 5: The first bank in the Pacific Northwest - KOBI-TV NBC5 / KOTI-TV NBC2

Comments Off on Unknown Stories Pt. 5: The first bank in the Pacific Northwest – KOBI-TV NBC5 / KOTI-TV NBC2
Jul 17th, 2020 | Filed under Testosterone

Testosterone Replacement Therapy Market Research 2020

The most recent research report published by Regal Intelligence presents a scientific analysis titled as worldwide Testosterone Replacement Therapy Market 2020. The report contemplates in a brief manner the presentation of both historical records alongside the ongoing patterns. It incorporates a complete analysis of various traits, for example, manufacturing base, type, and size. This report assesses the market division alongside the competitive landscape at worldwide as well as local level.

This study considers the Testosterone Replacement Therapy-value generated from the sales of the following segments:

The key manufacturers covered in this report: AbbVie, Pfizer, Eli Lilly, Teva Pharmaceuticals, Mylan, Bayer HealthCare Pharmaceuticals, Antares Pharma, Ferring Pharmaceuticals, Allergan, Antares Pharma, Sandoz, Clarus Therapeutics, Juniper Pharmaceuticals, Endo International, Acerus Pharmaceuticals, Forendo Pharma, MetP Pharma, Repros Therapeutics,

Segmentation by product type: Gels, Injectables, Patches, Other,

Segmentation by application: Hospitals, Clinics, Other

Get a Sample PDF Report: https://www.regalintelligence.com/request-sample/95904

The research report contemplates the market dependent on development opportunities, development restricting variables and attainability of investment. The report examines Testosterone Replacement Therapy Market areas and the present market portions will help the readers in organizing their business frameworks. It likewise shows future opportunities for the forecast years 2020-2024.

Market Segment by Regions, regional analysis covers:

The goal of the study is to characterize market elements, for example, patterns, components and obstructions affecting the market development. The report is intended to fuse both qualitative and quantitative parts of the worldwide business with respect to each of the region and country basis.

Get Discount On this Report: @ https://www.regalintelligence.com/check-discount/95904

The report has been readied dependent on the amalgamation, examination, and understanding of data about the Testosterone Replacement Therapy market 2020 collected from particular sources. Organization outline, monetary review, product portfolio, new venture propelled, recent advancement analysis are the parameters comprehended in the profile.

Table of Contents

Global Testosterone Replacement Therapy Market by Manufacturers, Regions, Type and Application, Forecast to 20261 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Testosterone Replacement Therapy Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Assessment by Type2.1 Gels Sales (K Units), Revenue (M USD) and Growth Rate 2014-20202.2 Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2014-20202.3 Patches Sales (K Units), Revenue (M USD) and Growth Rate 2014-20202.4 Other Sales (K Units), Revenue (M USD) and Growth Rate 2014-20203 Asia Pacific Testosterone Replacement Therapy Market Assessment by Type3.1 Asia Pacific Market Performance (Sales, Revenue)3.2 Key Players in Asia Pacific4 North America Testosterone Replacement Therapy Market Assessment by Type4.1 North America Market Performance (Sales, Revenue)4.2 Key Players in North America5 Europe Testosterone Replacement Therapy Market Assessment by Type4.1 Europe Market Performance (Sales, Revenue)4.2 Key Players in Europe6 South America Testosterone Replacement Therapy Market Assessment by Type4.1 South America Market Performance (Sales, Revenue)4.2 Key Players in South America7 Middle Easr and Africa Testosterone Replacement Therapy Market Assessment by Type4.1 Middle Easr and Africa Market Performance (Sales, Revenue)4.2 Key Players in Middle Easr and Africa

Read Complete Report with TOC: https://www.regalintelligence.com/request-toc/95904

To conclude the report sums up present analysis dependent on factors which are relied upon to show positive development of the market. The report studies market estimation for 2020 to 2026. Pertinently, the report and company profiles determine the key drivers that are affecting the interest in worldwide Testosterone Replacement Therapy markets.

Read the rest here:
Testosterone Replacement Therapy Market Research Report: Latest Industry Status and Future Growth Outlook - Cole of Duty

Comments Off on Testosterone Replacement Therapy Market Research Report: Latest Industry Status and Future Growth Outlook – Cole of Duty
Jul 16th, 2020 | Filed under Testosterone

Transparency Market Research (TMR) has published a new report titled, Testosterone Replacement Therapy Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192027. According to the report, the globalTestosterone Replacement Therapy marketwas valued at US$ 1,613.7 Mn in 2018 and is projected to expand at a CAGR of 4.4% from 2019 to 2027.

Overview

Growing Awareness about Testosterone Replacement Therapy to Drive Market

Request For Covid19 Impact Analysis https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1097

North America to Dominate Global Market

Buy Report Now :https://www.transparencymarketresearch.com/checkout.php?rep_id=1097&ltype=S

Read our Case study at :https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Competitive Landscape

The global Testosterone Replacement Therapy market has been segmented as follows:

More Trending Reports by Transparency Market Research 1.https://www.prnewswire.com/news-releases/global-chronic-obstructive-pulmonary-disease-copd-treatment-market-to-reach-us-26-2-bn-in-2027-drug-makers-focus-on-combination-therapies-transparency-market-research-301011476.html

View post:
Impact of the Coronavirus on Testosterone Replacement Therapy Market - Jewish Life News

Comments Off on Impact of the Coronavirus on Testosterone Replacement Therapy Market – Jewish Life News
Jul 16th, 2020 | Filed under Testosterone

COLLIER COUNTY

Collier County Sheriffs Office arrested a 37-year-old man on drug trafficking charges Wednesday after they found heroin, fentanyl and other drugs in his North Naples hotel room.

Joshua James Pyles of East Naples is charged with fentanyl trafficking, heroin trafficking, cocaine trafficking, amphetamine trafficking, and possession of a controlled substance.

CCSO says deputies pulled over Pyles outside the hotel he was staying at in the 4000 block of U.S. 41 North. During the stop, deputies determined that Pyles Florida drivers license was not valid.

Deputies also found methamphetamine in his possession.

Hotel management requested deputies assistance in evicting Pyles from the room he was renting. Deputies escorted Pyles to his room to retrieve his belongings. Pyles opened a dresser drawer where deputies saw small plastic bags containing what they suspected to be marijuana and methamphetamine.

CCSO says deputies conducted a field test on the methamphetamine which came back a positive reaction for amphetamines. Deputies halted the eviction process and began the process for a search warrant.

Around 4:30 p.m. detectives with the Vice and Narcotics Bureau, along with Special Enforcement Team deputies, executed a search warrant at the room where Pyles had been staying.

A search of the room turned up the following items: 166.1 grams of heroin 60 grams of fentanyl 414 grams of methamphetamine 139 grams of cocaine 24 grams of Adderall 52.2 grams of testosterone .6 grams of LSD

Deputies placed Pyles under arrest and transported him to the Collier County jail.

See the rest here:
East Naples man arrested with heroin, fentanyl, meth, cocaine and other drugs in a hotel room - Wink News

Comments Off on East Naples man arrested with heroin, fentanyl, meth, cocaine and other drugs in a hotel room – Wink News
Jul 16th, 2020 | Filed under Testosterone

Coherent Market Insights has recently published the Global research Report Titled Testosterone Replacement Therapy Market. The study provides an overview of current statistics and future predictions of the Testosterone Replacement Therapy Market. The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data.

The Global Testosterone Replacement Therapy Market research report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the in each region. Various methodological tools are used to analyze the growth of the worldwide Testosterone Replacement Therapy Market.

To learn more about this report, request a samplecopy:https://www.coherentmarketinsights.com/insight/request-sample/2024

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, and Methodology.

Prominent Key Players Covered in the report:

AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Detailed Segmentation:

By Active Ingredient TypeTestosteroneMethyl TestosteroneTestosterone UndecanoateTestosterone EnanthateTestosterone CypionateBy Route of AdministrationInjectablesParenteral

Major Regions as Follows:

North America (USA, Canada and Mexico)

Europe (Germany, France, the United Kingdom, Netherlands, Russia , Italy and Rest of Europe)

Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia, rest of countries etc.)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria and South Africa)

How Does This Market Insights Help?

Testosterone Replacement Therapy Market share (regional, product, application, end-user) both in terms of volume and revenue along with CAGR

Key parameters which are driving this market and restraining its growth

What all challenges manufacturers will face as well as new opportunities and threats faced by them

Learn about the market strategies that are being adopted by your competitors and leading organizations

To gain insightful analyses of the market and have a comprehensive understanding of the Testosterone Replacement Therapy Market and its commercial landscape

Key Pointers Covered in the Industry Trends and Forecast to 2027

Current and future of global Testosterone Replacement Therapy Market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/2024

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers and Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

In conclusion, the Testosterone Replacement Therapy Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

Customization of the Report:

Coherent Market Insights also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Need a discount?

Request discount for this report @https://www.coherentmarketinsights.com/insight/request-discount/2024

Note: *The discount is offered on the Standard Price of the report.an

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact:

US +1-206-701-6702

UK +44-020 8133 4027[emailprotected]

Read more:
Impact of COVID-19 on Testosterone Replacement Therapy Market How will Growth Develop And Forecast to 2027 | Endo Pharmaceuticals, Inc., Eli Lilly and...

Comments Off on Impact of COVID-19 on Testosterone Replacement Therapy Market How will Growth Develop And Forecast to 2027 | Endo Pharmaceuticals, Inc., Eli Lilly and…
Jul 16th, 2020 | Filed under Testosterone

by: Erin Coulehan and Nexstar Media Wire

EL PASO, Texas (KTSM) Scientists and medical experts are grappling to learn as much as possible about the biological impact of COVID-19 on the body.

New research examining COVID-19 and human sperm suggests potential risks for male infertility as well as sexual transmission.

A study published last month in JAMA analyzed semen samples of 38 COVID-19 patients and found the presence of the virus in 15% of them.

According to researcher Dr. John Aitken, COVID-19s pathological impact on those tested is underscored by data that shows active cases dramatically reduce testosterone to luteinizing hormones. Reduction in testosterone has a significant impact on the bodys responsiveness to Leydig cells, which stimulate the secretion of sex steroids.

Aitken said the finding is to be expected because the blood-testis barriers offer little defense against viral invasion. Pathogenic viruses such as HIV, hepatitis, mumps and HPV have been linked to testes damage that causes host infertility. The presence of the virus in the testes also leaves the host susceptible to transmitting the disease to sexual partners.

It should be emphasized spermatozoa have a demonstrable capacity to carry viral infections from the male to the female reproductive tract, said Aitken. As happens during the sexual transmission of Zika, for example. Zika virusis a mostly mosquito-borne virus that can also be sexually transmitted.

With the coronavirus, the corona-shaped spike that gives the virus its name targets ACE2 enzymes that are found in many testes cell types. Additionally, the COVID-19 virus may also gain access to male sperm cells once they leave the testes, which could be very dangerous in terms of transmission.

Mature sperm have all the equipment needed to bind and fuse with COVID-19, and then reverse transcription of viral RNA into proviral DNA. The reverse transcription produces double-stranded DNA that is integrated into the genetic material of the person. This means that human sperm can act as a vehicle for sexually-transmitted COVID-19 transmission.

A COVID-19 attack on human sperm leads to a build-up of angiotensin II, which is a hormone that regulates kidney function and blood pressure. Increased levels of this hormone cause an immune response against the invading COVID-19 virus particles that increases the availability of reactive oxygen species that causes cell death.

Prolonged exposure to elevated angiotenstin II levels can lead to cell death in sperm.

The available research suggests that when the ACE2 enzyme cleaves at specific amino acids, the exposure causes decreased sperm viability and function and can ultimately result in a loss of male fertility.

Originally posted here:
Coronavirus can cause male infertility and be transmitted sexually according to new research - WJW FOX 8 News Cleveland

Comments Off on Coronavirus can cause male infertility and be transmitted sexually according to new research – WJW FOX 8 News Cleveland
Jul 16th, 2020 | Filed under Testosterone

BATON ROUGE, La. (KLFY) A newly hired corrections cadet at Elayn Hunt Correctional Center in St. Gabriel has been accused of attempting to smuggle contraband to inmates at the prison, according to the Louisiana Department of Public Safety and Corrections.

Spokesperson Ken Pastorick says officers at the prison arrested 21-year-old Paige Destanie M. Ruiz of Prairieville.

He said investigators found a paper bag with six cell phones, 45 pieces of loose-leaf paper sprayed with a substance suspected to be synthetic cannabinoid enclosed in clear bags, a four-ounce clear bottle of a liquid substance suspected of being cough syrup with codeine, 250 pills suspected to be MDMA (ecstasy), three packs of tobacco, 42 Nugenix Total-T testosterone pills, five taped bundles of suspected illicit substances containing 200 grams, and 26 cell phone manuals with activation packages, and two cigars in her front pants pocket.

Investigators also found a loaded 9mm semi-automatic pistol, several containers of alcohol, and one glass bottle of hand sanitizer inside of her car, Pastorick said.

Authorities were aware Ruiz was attempting to make a drop and did a stake out at the prison.

Ruiz was arrested and booked into the Iberville Parish Prison on eight counts of introduction of contraband into a penal institution, malfeasance in office, possession with intent to distribute MDMA, possession with intent to distribute marijuana, possession with intent to distribute synthetic cannabinoids, and possession of a firearm while in possession of a controlled substance.

Ruiz had been a probational employee since May 11, 2020 Pastorick said.

Continue reading here:
Newly hired corrections cadet accused of attempting to smuggle contraband, into Elayn Hunt correctional center - BRProud.com

Comments Off on Newly hired corrections cadet accused of attempting to smuggle contraband, into Elayn Hunt correctional center – BRProud.com
Jul 16th, 2020 | Filed under Testosterone

Global Testosterone Replacement Therapy Market Research Report gives knowledgeable information on various market situations, for example, potential development factors, factors controlling the development, market opportunities and hazards to the worldwide market.

The report broadly centres around the competitive analysis of Testosterone Replacement Therapy Market. The competitive analysis segment incorporates key manufacturers, fresh players, providers, market strategies, potential chances, operation landscape and analysis of the trends of the Testosterone Replacement Therapy Industry. The market results are centred around the current market scenario. To gauge and predict the degree of competition in this market. This report will likewise support all the manufacturers and speculators to have a superior comprehension of the investments to know where the market is heading.

Industry Analysis by Key Players: AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals,,, etc.

Market Analysis by Type: Gels, Injections, Patches, Other,,, etc.

Market Analysis by Applications: Hospitals, Clinics, Others,,, etc.

Get Exclusive Sample of this [emailprotected] https://www.regalintelligence.com/request-sample/149892

Report on Global Testosterone Replacement Therapy Market 2019 comprises of 10 Sections in Table as follows:

The Testosterone Replacement Therapy-market report reads pin-direct analysis for changing serious dynamics with deference towards changing elements that drives or limits market development. It is visualized to comprehend the market point of view and opportunities where it has an extension to develop in future. Basically, the report segregates the ability of the market in the present and the future possibilities from various edges in detail.

Get Exclusive [emailprotected] https://www.regalintelligence.com/check-discount/149892

Table of Contents

Chapter 1 Testosterone Replacement Therapy Market Overview1.1 Testosterone Replacement Therapy Definition1.2 Global Testosterone Replacement Therapy Market Size Status and Outlook (2014-2029)1.3 Global Testosterone Replacement Therapy Market Size Comparison by Region (2014-2029)1.4 Global Testosterone Replacement Therapy Market Size Comparison by Type (2014-2029)1.5 Global Testosterone Replacement Therapy Market Size Comparison by Application (2014-2029)1.6 Global Testosterone Replacement Therapy Market Size Comparison by Sales Channel (2014-2029)1.7 Testosterone Replacement Therapy Market Dynamics (COVID-19 Impacts)1.7.1 Market Drivers/Restraints1.7.2 COVID-19 Impacts on Current Market1.7.3 Post-Strategies of COVID-19 OutbreakChapter 2 Testosterone Replacement Therapy Market Segment Analysis by Player2.1 Global Testosterone Replacement Therapy Sales and Market Share by Player (2017-2019)2.2 Global Testosterone Replacement Therapy Revenue and Market Share by Player (2017-2019)2.3 Global Testosterone Replacement Therapy Average Price by Player (2017-2019)2.4 Players Competition Situation & Trends2.5 Conclusion of Segment by PlayerChapter 3 Testosterone Replacement Therapy Market Segment Analysis by Type3.1 Global Testosterone Replacement Therapy Market by Type3.1.1 Gels3.1.2 Injections3.1.3 Patches3.1.4 Other3.2 Global Testosterone Replacement Therapy Sales and Market Share by Type (2014-2019)3.3 Global Testosterone Replacement Therapy Revenue and Market Share by Type (2014-2019)3.4 Global Testosterone Replacement Therapy Average Price by Type (2014-2019)3.5 Leading Players of Testosterone Replacement Therapy by Type in 20193.6 Conclusion of Segment by TypeChapter 4 Testosterone Replacement Therapy Market Segment Analysis by Application4.1 Global Testosterone Replacement Therapy Market by Application4.1.1 Hospitals4.1.2 Clinics4.1.3 Others4.2 Global Testosterone Replacement Therapy Sales and Market Share by Application (2014-2019)4.3 Leading Consumers of Testosterone Replacement Therapy by Application in 20194.4 Conclusion of Segment by ApplicationChapter 5 Testosterone Replacement Therapy Market Segment Analysis by Sales Channel5.1 Global Testosterone Replacement Therapy Market by Sales Channel5.1.1 Direct Channel5.1.2 Distribution Channel5.2 Global Testosterone Replacement Therapy Sales and Market Share by Sales Channel (2014-2019)5.3 Leading Distributors/Dealers of Testosterone Replacement Therapy by Sales Channel in 20195.4 Conclusion of Segment by Sales Channel

Ask For Table of [emailprotected] https://www.regalintelligence.com/request-toc/149892

Thank You.

See more here:
Potential impact of COVID-19 on Testosterone Replacement Therapy market: Industry outlook, latest trends, growth story to 2029 - Cole of Duty

Comments Off on Potential impact of COVID-19 on Testosterone Replacement Therapy market: Industry outlook, latest trends, growth story to 2029 – Cole of Duty
Jul 15th, 2020 | Filed under Testosterone
Weight Loss Solutions